- Home
- TNC vs IMCR Comparison
TNC vs IMCR Comparison
Compare TNC & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNC
- IMCR
- Stock Information
- Founded
- TNC 1870
- IMCR 2008
- Country
- TNC United States
- IMCR United Kingdom
- Employees
- TNC N/A
- IMCR N/A
- Industry
- TNC Industrial Machinery/Components
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TNC Industrials
- IMCR Health Care
- Exchange
- TNC Nasdaq
- IMCR Nasdaq
- Market Cap
- TNC 1.4B
- IMCR 1.5B
- IPO Year
- TNC N/A
- IMCR 2021
- Fundamental
- Price
- TNC $81.98
- IMCR $32.80
- Analyst Decision
- TNC Strong Buy
- IMCR Buy
- Analyst Count
- TNC 1
- IMCR 10
- Target Price
- TNC $125.00
- IMCR $58.13
- AVG Volume (30 Days)
- TNC 146.7K
- IMCR 444.9K
- Earning Date
- TNC 08-07-2025
- IMCR 08-07-2025
- Dividend Yield
- TNC 1.44%
- IMCR N/A
- EPS Growth
- TNC N/A
- IMCR N/A
- EPS
- TNC 3.58
- IMCR N/A
- Revenue
- TNC $1,265,700,000.00
- IMCR $333,581,000.00
- Revenue This Year
- TNC N/A
- IMCR $26.82
- Revenue Next Year
- TNC $4.25
- IMCR $8.15
- P/E Ratio
- TNC $22.89
- IMCR N/A
- Revenue Growth
- TNC 1.35
- IMCR 25.75
- 52 Week Low
- TNC $67.32
- IMCR $23.15
- 52 Week High
- TNC $110.45
- IMCR $41.54
- Technical
- Relative Strength Index (RSI)
- TNC 71.58
- IMCR 51.47
- Support Level
- TNC $76.96
- IMCR $30.76
- Resistance Level
- TNC $78.67
- IMCR $33.95
- Average True Range (ATR)
- TNC 1.58
- IMCR 1.39
- MACD
- TNC 0.72
- IMCR -0.15
- Stochastic Oscillator
- TNC 95.18
- IMCR 43.05
About TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.